Synonym |
Thai / English name |
Part Used : ไม่ระบุActivity : CYP1A1 INHIBITIONSolvent/Active Compound : -Type of experiment : in vivoType of animal : mouseType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : 2.5% decaffeinated black tea ext. (DBTE)Duration : 15 daysType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Treatment with 2.5% decaffeinated black tea ext. (DBTE) or 1% polymeric black tea polyphenol (PBP) mix did not significantly alter the basal activity and level of CYP1A1 and CYP1A2.Note : Data incomplete
Part Used : ไม่ระบุActivity : CYP1A1 INHIBITIONSolvent/Active Compound : polyphenolType of experiment : in vivoType of animal : mouseType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : 1% polymeric black tea polyphenol (PBP)Duration : 15 daysType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Treatment with 2.5% decaffeinated black tea ext. (DBTE) or 1% polymeric black tea polyphenol (PBP) mix did not significantly alter the basal activity and level of CYP1A1 and CYP1A2.Note : Data incomplete
Part Used : ไม่ระบุActivity : CYP1A1 INHIBITIONSolvent/Active Compound :Type of experiment : in vivoType of animal : mouseType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : 2.5% decaffeinated black tea ext. (DBTE)Duration : 15 daysType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) :Result : PositiveRemark : Pretreatment with 2.5% decaffeinated black tea ext. (DBTE) or 1% polymeric black tea polyphenol (PBP) mix resulted in a significant decrease in both the activity and the level of B(a)P-induced CYP1A1 and CYP1A2 in liver and lungs.Note : Data incomplete
Part Used : ไม่ระบุActivity : CYP1A1 INHIBITIONSolvent/Active Compound : -Type of experiment : in vivoType of animal : mouseType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : 1% polymeric black tea polyphenol (PBP)Duration : 15 daysType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) :Result : NegativeRemark : Pretreatment with 2.5% decaffeinated black tea ext. (DBTE) or 1% polymeric black tea polyphenol (PBP) mix resulted in a significant decrease in both the activity and the level of B(a)P-induced CYP1A1 and CYP1A2 in liver and lungs.Note : Data incomplete
Part Used : -Activity : CYP1A1 INHIBITIONSolvent/Active Compound : tea melaninType of experiment : in vivoType of animal : mouseType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : 40 mg/kgDuration : 14 daysType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Both reduced tea melanin and non-reduced tea melanin suppressed the expression of CYP1A1 gene and prevented the activation of cytochrome P 450 isoenzyme in the livers of animals exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.Note : Data incomplete
Part Used : ใบActivity : CYP1A1 INHIBITIONSolvent/Active Compound : Black tea polyphenolType of experiment : in vivoType of animal : otherType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : -Duration : 4 weeks before carcinogen administrationType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Administration of polyphenon-B significantly decreased tumor incident, oxidative DNA damage, phase I enzymes (CYP450; CYP1A1, 1A2 and 2B isoforms and cytochrome b5) as well as expression of CYP1A1 and CYP1B1 isoforms.Note : Data incomplete. Type of animal = hamster
Part Used : ใบActivity : CYP1A1 INHIBITIONSolvent/Active Compound : Black tea polyphenolType of experiment : in vivoType of animal : otherType of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : Oral administrationDose/Conc.(herb) : -Duration : 4 weeks after carcinogen administrationType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Administration of BTF-35 significantly decreased tumor incident, oxidative DNA damage, phase I enzymes (CYP450; CYP1A1, 1A2 and 2B isoforms and cytochrome b5) as well as expression of CYP1A1 and CYP1B1 isoforms.Note : Data incomplete. Type of animal = hamster